Gilead Sciences
GILD
#105
Rank
NZ$292.45 B
Marketcap
NZ$235.69
Share price
1.72%
Change (1 day)
38.96%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$17.01 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.08 Billion. In 2024 the company made an earning of NZ$1.14 Billion a decrease over its 2023 earnings that were of NZ$11.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$17.01 B1385.52%
2024 NZ$1.14 B-89.94%
2023 NZ$11.38 B17.97%
2022 NZ$9.65 B-29.77%
2021 NZ$13.74 B395.99%
2020 NZ$2.77 B-67.66%
2019 NZ$8.56 B-33.84%
2018 NZ$12.94 B-42.35%
2017 NZ$22.46 B-20.87%
2016 NZ$28.38 B-21.06%
2015 NZ$35.96 B45.8%
2014 NZ$24.66 B253.01%
2013 NZ$6.98 B16.51%
2012 NZ$5.99 B-1.07%
2011 NZ$6.06 B-6.71%
2010 NZ$6.49 B11.75%
2009 NZ$5.81 B29.5%
2008 NZ$4.49 B19.11%
2007 NZ$3.76 B-455.74%
2006 -NZ$1.06 Billion-154.93%
2005 NZ$1.92 B76.99%
2004 NZ$1.08 B-266.16%
2003 -NZ$0.66 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$92.67 M-242.15%
2000 -NZ$65.2 Million-40.2%
1999 -NZ$0.11 Billion31.85%
1998 -NZ$82.69 Million8.73%
1997 -NZ$76.05 Million27.22%
1996 -NZ$59.78 Million
1994 -NZ$56.96 Million26.57%
1993 -NZ$45 Million46.49%
1992 -NZ$30.72 Million362.5%
1991 -NZ$6.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.67 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.75 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.36 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.68 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.16 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.65 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.40 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.33 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA